Connect with us

Technology

Quantinuum, Rolls-Royce, Riverlane and University of Edinburgh Sign Agreement to Explore Quantum Computing for Industrial Design and Simulation

Published

on

Collaboration will explore how fault-tolerant quantum computing could advance complex fluid dynamics simulations, including for uses in gas turbine designProject aims to combine Quantinuum’s Helios platform, the world’s most accurate commercial quantum computer[1], Rolls-Royce’s industrial applications, Riverlane’s quantum error correction and fault-tolerant algorithm expertise, and EPCC’s supercomputing expertiseCollaboration will help advance the UK quantum strategy by developing the quantum technologies and hybrid computing capabilities needed for future industrial applications

BROOMFIELD, Colo. and CAMBRIDGE, England, July 14, 2026 /CNW/ — Quantinuum Inc. (NASDAQ:QNT), Rolls-Royce, Riverlane and EPCC, the UK National Supercomputing Centre based at the University of Edinburgh, today announced an agreement to explore the quantum computing capabilities needed in future industrial workflows, such as gas turbine design.

Under the agreement, Quantinuum will provide access to its quantum systems and software environment; Rolls-Royce will contribute industrial design use cases and domain expertise; Riverlane will contribute quantum error correction and algorithmic expertise; and EPCC will contribute supercomputing expertise and hybrid workflow integration.

Complex fluid dynamics simulations are central to gas turbine design, but they can require substantial computing resources as models become more detailed. In what is expected to be a multi-year collaboration, the partners will explore how fault-tolerant quantum computers could work alongside supercomputers to address this bottleneck, and accurately model fluid dynamics inside gas turbines.

“The computing demands of simulating complex fluid dynamics are a major challenge in industrial design, and exploring how quantum computing can complement today’s supercomputers is an important step toward addressing them,” said Dr. Rajeeb Hazra, President and CEO of Quantinuum. “This collaboration will help develop and test the hybrid quantum-classical algorithms needed for future industrial applications.”

The collaborators plan to test key computational building blocks for industrially relevant quantum algorithms on Quantinuum’s Helios quantum computer and assess how these could scale on planned future systems, such as Sol and Apollo.

This project builds on prior collaborations between Rolls-Royce, Riverlane and EPCC that laid the foundations for understanding key algorithmic, error correction and data requirements for tackling fluid dynamic simulations with commercial quantum computers.

“We have been developing and improving algorithms for hybrid fault-tolerant applications for almost five years with Riverlane, using classical emulators in collaboration with EPCC. This agreement marks the start of an exciting new phase where we work together to explore their implementations on Quantinuum’s hardware,” said Leigh Lapworth, Fellow in Computational Science at Rolls-Royce. “Applications development is a multi-year activity and if we want to be in a position to benefit from teraQuOp devices, we have to start now, co-developing the algorithms, hardware and software.”

“Riverlane specialises in quantum error correction (QEC), as the critical technology that will ultimately unlock large fault-tolerant quantum computing, and fault-tolerant applications for various industries,” said Steve Brierley, CEO and Founder of Riverlane. “Building on our work with Rolls-Royce and EPCC, collaborating with Quantinuum will help us explore how fault-tolerant quantum computing and hybrid quantum-HPC approaches can accelerate the path to industrial quantum computing.”

EPCC will contribute its expertise in high-performance computing, simulations and the software interfaces needed to connect quantum and classical systems. Its role includes exploring how different parts of an algorithm can be compiled, emulated and executed across classical and quantum resources, including pre- and post-processing steps required for hybrid compute workflows.

“Quantum computing will be most valuable when users can exploit it within a wider computing environment, and EPCC has been working towards hybrid HPC and quantum since my appointment as a Chancellor’s Fellow in 2023,” said Oliver Thomson Brown, Quantum Group lead at EPCC. “EPCC’s mission is to accelerate the effective use of novel computing across industry and academia, and this project is a natural fit with the goals of the UK’s first National Supercomputing Centre.”

The UK’s quantum computing mission aims to develop accessible, UK-based quantum computers capable of one trillion error-free operations, known as “teraQuOp” systems. The collaboration and its anticipated multi-year timeline support the UK Government’s quantum computing mission and reflect the strength and maturity of the UK’s quantum and advanced computing ecosystem in moving from foundational research toward industrially relevant hybrid applications.

About Quantinuum

Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of trapped-ion based quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity.[2] Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets, as well as academic and research institutions globally.

The company has a global workforce of approximately 700 employees, including top scientists and researchers. Over 70% of its technology team holds PhDs or Master’s degrees. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar, and Singapore.

For more information, please visit www.quantinuum.com.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. The words “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable,” the negative version of these words, or similar terms and phrases are intended to identify forward-looking statements. Such statements are based on certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. New factors emerge from time to time, and it is not possible for Quantinuum to predict all such factors. Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, Quantinuum does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

[1] based on its high two-qubit gate fidelity supporting 98 physical qubits
[2] As of December 31, 2025.

View original content to download multimedia:https://www.prnewswire.com/news-releases/quantinuum-rolls-royce-riverlane-and-university-of-edinburgh-sign-agreement-to-explore-quantum-computing-for-industrial-design-and-simulation-302824055.html

SOURCE Quantinuum

Continue Reading

Technology

APPOINTMENT OF CHAIRMAN OF THE AUDIT COMMITTEE

Published

on

By

JOHANNESBURG, Nov. 13, 2026 /PRNewswire/ — In compliance with para 6.71 of the JSE Listings Requirements and para 6.42 of the JSE Debt and Specialist Securities Listings Requirements, Sasol is pleased to announce the appointment of Mr Stanley Subramoney as the Chairman of the Audit Committee and Sasol’s financial expert with effect from 14 November 2026.

Mr Subramoney has been an independent non-executive director of Sasol Limited since 2021 and is a member of the Audit and Remuneration Committees. He is a chartered accountant with extensive experience in accounting, auditing and international business. During a 27-year career with PwC, he served as an audit and advisory partner and Deputy Chief Executive Officer of PwC Southern Africa. He gained significant international exposure through complex assignments and global organisational roles. He is currently Chief Executive Officer of Menston Holdings, a diversified investment company. He serves as an independent non-executive director of Nedbank Group, where he formerly chaired the Group Audit and Credit Committees.

The Chairman of the Sasol Board, Ms Muriel Dube, said: “Stanley has been a valued member of the Sasol Board and Audit Committee since 2021. His extensive accounting and audit expertise, together with his deep knowledge of Sasol gained during his tenure on the Board, position him well to lead the Audit Committee. The Board is confident that he will provide strong leadership to the Committee and continue to make a valuable contribution to Sasol.”

For further information, please contact:
Sasol Investor Relations,
Tiffany Sydow, VP Investor Relations
Telephone: +27 (0) 71 673 1929
investor.relations@sasol.com

 

View original content:https://www.prnewswire.com/news-releases/appointment-of-chairman-of-the-audit-committee-302938758.html

SOURCE Sasol Limited

Continue Reading

Technology

CCTV4: The special coverage APEC: Shenzhen Engagement will air

Published

on

By

BEIJING, Nov. 13, 2026 /PRNewswire/ — The 2026 APEC Summit will be held in Shenzhen, Guangdong Province, on November 18–19, attracting global attention. China Media Group’s Chinese Global Program Center has set up a front-line studio in Shenzhen. From November 13 to 19, China News will launch the special coverage APEC: Shenzhen Engagement in its flagship noon and evening slots. Adopting an international perspective and centered on the theme of “Building an Asia-Pacific Community for Common Prosperity”, the special coverage will present a comprehensive and multi-dimensional picture of the APEC Summit in Shenzhen through a rich array of reporting formats, including live broadcasts, studio discussions, high-profile interviews, and integrated-media live streams.

Guests from the China (Shenzhen) Development Institute and other institutions will be invited to the studio to discuss new models of global governance under the APEC cooperation framework amid key summit topics.

APEC Face to Face, a high-end interview segment, will feature exclusive conversations with attending dignitaries, senior officials of APEC economies, industry leaders, business figures, heads of multinational corporations and authoritative think tank experts. It combines dedicated in-depth interviews with on-the-spot interviews to capture hot topics of Asia-Pacific cooperation.

The integrated-media program Shenzhen’s New Landmarks uses six core landmark clusters across Shenzhen as its narrative thread. It integrates mobile live streaming, immersive exploration, feature videos and in-depth interviews to offer a panoramic view of Shenzhen’s development achievements and practical experience as a pioneer of China’s reform and opening up and a core engine of the Guangdong-Hong Kong-Macao Greater Bay Area.

The special coverage APEC: Shenzhen Engagement will air on China Media Group’s CCTV-4 (Chinese International Channel) at 12:00 and 18:00 from November 13 to 19. Stay tuned!

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/cctv4-the-special-coverage-apec-shenzhen-engagement-will-air-302938759.html

SOURCE CCTV4

Continue Reading

Technology

Bracco and Avicenna.AI Announce FDA Clearance for UPTUNITY™ | Aneurysm, a New AI-Enabled Software for Brain Aneurysm Detection and Assessment

Published

on

By

Developed in collaboration with Avicenna.AI, the newly FDA-cleared technology introduces UPTUNITY™, Bracco’s new portfolio of AI-enabled clinical decision support solutions.

MILAN, Nov. 13, 2026 /PRNewswire/ — Bracco and Avicenna.AI today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of UPTUNITY™ | Aneurysm, the first offering within the new UPTUNITY™ portfolio and a result of Bracco’s collaboration with Avicenna.AI. Designed to support medical specialists in detecting and assessing brain aneurysms on cerebral arteries computed tomography angiography (CTA) images, UPTUNITY | Aneurysm integrates AI assistance into the radiologist’s reading workflow.

UPTUNITY reinforces Bracco’s Digital Health strategy by expanding the company’s capabilities into interpretive AI. The portfolio provides clinical decision support capabilities for specific needs in image interpretation. It complements Bracco’s existing AI offerings, including AiMIFY®, developed with Subtle Medical, which applies AI to amplify existing contrast enhancement in brain MRI for improved lesion visualization.1 With UPTUNITY, Bracco continues to invest in Digital Health technologies that extend its support for radiologists across the imaging continuum and advance innovation beyond contrast agents.

“A small incidental aneurysm on a head CTA can easily be overlooked when the worklist keeps growing,” said Cosimo DePinto, Executive Vice President, Marketing & Commercial Operations, Bracco Americas. “UPTUNITY | Aneurysm works inside the reading environment radiologists already know and helps find the aneurysm hiding in the CT scan. The clinical decision stays where it belongs: with the radiologist.”

An estimated one in 50 U.S. adults has an unruptured brain aneurysm, a condition that is often asymptomatic.2 Aneurysms can be difficult to detect on cerebral arteries CTA and may be discovered incidentally during imaging performed to evaluate other clinical concerns.3,4 For known aneurysms, consistent follow-up and assessment of changes in growth are important to ongoing clinical evaluation.4

UPTUNITY | Aneurysm spans brain aneurysm detection and ongoing follow-up across the radiologist’s workflow. For detection, the computer-assisted detection (CADe) and diagnosis (CADx) software is intended for use as a concurrent reading aid by appropriately trained medical specialists. It identifies suspected saccular brain aneurysms greater than 3 mm on head CTA images and provides information about their presence, location and size for assessment and characterization. For known aneurysms, the follow-up functionality (MIMPS) provides quantitative measurements and comparison between examinations to assess changes over time. The integrated workflow extends from initial identification through longitudinal follow-up.

The software provides information for use alongside review of the CTA images, while maintaining physician control over clinical decision-making. It is not intended to replace a full patient evaluation or a qualified physician’s review and should not be solely relied upon to make or confirm a diagnosis.5,6

“For a patient with an unruptured aneurysm, the follow-up scan always brings the same question: has it changed?” said Fabio Tedoldi, PhD, Head of Global Research & Development, Bracco Imaging. “UPTUNITY | Aneurysm supports physicians from first detection through subsequent monitoring, with comparable readings at every exam. Precision, to us, means not only finding, but following up.”

Bracco and Avicenna.AI announced their strategic partnership in March 2026 to advance AI applications in contrast-enhanced computed tomography. The companies are now preparing for the commercial introduction of UPTUNITY | Aneurysm in the United States. Avicenna.AI will lead promotion and commercial distribution of the solution.

“Contrast agents were created to make the invisible visible. A brain aneurysm is exactly that kind of hidden finding: silent, often discovered by chance, then followed millimeter by millimeter for years. Bracco has spent decades lighting up the vessels. But an image only helps if what it shows is seen. Avicenna.AI brings AI assistance to those images, helping radiologists detect an aneurysm >3 mm and track how it changes over time,” said Cyril Di Grandi, CEO and co-founder, Avicenna.AI. “UPTUNITY | Aneurysm combines these two strengths, turning a head CTA into a story the radiologist can follow, from the first finding through every follow-up. Neither of us could have done this alone, and that is the point of this partnership.”

UPTUNITY | Aneurysm will be showcased at the Radiological Society of North America (RSNA) 2026 Annual Meeting, taking place November 29–December 3 in Chicago. To learn more about Bracco’s presence at RSNA 2026, including UPTUNITY | Aneurysm and the company’s vision for artificial intelligence, visit www.bracco.com/RSNA.

UPTUNITY | Aneurysm has received 510(k) clearance from the U.S. Food and Drug Administration under K262062 and K262147. UPTUNITY™ | Aneurysm Detection and UPTUNITY™ | Aneurysm Management are the commercial names for CINA-Aneurysm (K262062) and CINA-Aneurysm+ (K262147), respectively. For complete operating instructions, warnings, precautions and other important safety information, refer to the instructions for use.

About Bracco
Bracco Group, founded in 1927, is a global leader in diagnostic imaging committed to advancing healthcare and improving people’s lives by shaping the future of prevention and precision medicine. The company operates in the healthcare sector in more than 100 countries, with a workforce of over 4,000 employees and consolidated annual revenues of approximately €2 billion, with a global footprint.

With a strong commitment to innovation, investing around 9% of its reference turnover in research and development, Bracco develops and provides a broad portfolio of pharmaceutical products for diagnostic imaging, including contrast agents for X-ray, computed tomography and magnetic resonance imaging, as well as microbubbles for contrast-enhanced ultrasound and molecular imaging agents such as radioactive tracers and novel positron emission tomography imaging agents, alongside artificial intelligence-based solutions. It is also a global market leader in advanced contrast management technologies for cardiovascular angiography and radiology imaging. Discover more at www.bracco.com.

About Avicenna.AI
Founded in 2018, Avicenna.AI specializes in the development of artificial intelligence solutions dedicated to emergency and incidental medical imaging, using deep learning techniques to identify, detect and quantify critical pathologies from CT images. Co-founded by Cyril Di Grandi, co-founder of Olea Medical, and Dr. Peter Chang, American radiologist and AI expert, Avicenna.AI’s mission is to support radiologists’ diagnosis, ensure faster and more reliable detection of serious pathologies, and improve the quality of patient care through its AI tools for radiology. For more information, follow us on LinkedIn and visit our website: www.avicenna.ai

Media Contacts:

Bracco Press Contact
Alessandra Vulpiani
Bracco Imaging, Senior Marketing Communication Manager
Alessandra.Vulpiani@bracco.com

Avicenna.AI Press Contact
Stéphanie Bellavia
Avicenna.AI, Marketing Manager
stephanie.bellavia@avicenna.ai

1Venkata SP, Arnold TC, Serra SC, et al. Deep-Learning Based Contrast Boosting: A Multi-Center Multi-Reader Study on Clinical Performance With Standard Contrast Enhanced Brain MRI. J Magn Reson Imaging. 2026:1-15. doi:10.1002/jmri.70460.
2Brain Aneurysm Foundation. Brain Aneurysm Statistics and Facts. Available at: https://www.bafound.org/statistics-and-facts/. Accessed October 28, 2026.
3Biddle G, Assadsangabi R, Broadhead K, Hacein-Bey L, Ivanovic V. Diagnostic Errors in Cerebrovascular Pathology: Retrospective Analysis of a Neuroradiology Database at a Large Tertiary Academic Medical Center. AJNR Am J Neuroradiol. 2022;43(9):1271-1278. doi:10.3174/ajnr.A7596
4Thompson BG, Brown RD Jr, Amin-Hanjani S, et al. Guidelines for the Management of Patients With Unruptured Intracranial Aneurysms: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015;46(8):2368-2400.
5U.S. Food and Drug Administration. 510(k) Summary K262062, CINA-Aneurysm.
6U.S. Food and Drug Administration. 510(k) Summary K262147, CINA-Aneurysm+.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/bracco-and-avicennaai-announce-fda-clearance-for-uptunity–aneurysm-a-new-ai-enabled-software-for-brain-aneurysm-detection-and-assessment-302938510.html

Continue Reading

Trending